Work

Lorlatinib-induced remission in refractory acute myeloid leukemia with an anaplastic lymphoma kinase fusion

Year: 2026

Type: article

Source: Haematologica

DOI: 10.3324/haematol.2026.300893

Authors: Leora Boussi, Natalia Tijaro Ovalle, Brandon S. Imber, Mark D. Ewalt, Michael Glick, Brian Shaffer, Eytan M. Stein

Institutions: Memorial Sloan Kettering Cancer Center, NYU Langone Health, New York University

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

Funders: AstraZeneca, Syndax Pharmaceuticals, Astellas Pharma, Servier, National Institutes of Health, Genentech, National Cancer Institute

Award: Clinical Scholars Biomedical Research Training Program

OpenAlex ID: W7162675518

FWCI:

Cites:

Cited by:

Related to: 10